Approval · Notice of Compliance 13660 · 2012
COMBIGAN: Notice of Compliance 13660
Issued September 18, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13660
- Date
- September 18, 2012
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturer for timolol maleate
- Therapeutic class
- Elevated Intraocular Pressure Therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMBIGAN | Not yet assigned | — |
Medicinal ingredients
- TIMOLOL MALEATE 0.5 PER
- BRIMONIDINE TARTRATE 0.2 PER